Clinical Trial Update: Prospective Evaluation of T-cell Immune Status in Patients With Newly Diagnosed High Grade Gliomas [NA]

View source ↗

Summary

An update on a prospective clinical trial evaluating T-cell immune status in patients with newly diagnosed high-grade gliomas. The study status is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• High-grade Glioma

Snippet

Sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | Conditions: High Grade Glioma | NA | Status: COMPLETED